Charles Moore
Stock Analyst at Robert W. Baird
(2.07)
# 3,270
Out of 4,974 analysts
9
Total ratings
62.5%
Success rate
3.1%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Charles Moore
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CTNM Contineum Therapeutics | Reiterated: Buy | $20 → $19 | $13.82 | +37.48% | 3 | Sep 15, 2026 | |
| DNLI Denali Therapeutics | Reiterated: Buy | $34 | $20.38 | +66.83% | 3 | Aug 7, 2026 | |
| DRUG Bright Minds Biosciences | Reiterated: Buy | $142 → $126 | $60.22 | +109.23% | 3 | Feb 13, 2026 |
Contineum Therapeutics
Sep 15, 2026
Reiterated: Buy
Price Target: $20 → $19
Current: $13.82
Upside: +37.48%
Denali Therapeutics
Aug 7, 2026
Reiterated: Buy
Price Target: $34
Current: $20.38
Upside: +66.83%
Bright Minds Biosciences
Feb 13, 2026
Reiterated: Buy
Price Target: $142 → $126
Current: $60.22
Upside: +109.23%